Carbon-13 magnetic resonance spectroscopy (MRS) following oral intake of 13 C-labeled glucose is the gold standard for imaging glycogen metabolism in humans. However, the temporal resolution of previous studies has been >13 minutes.
H epatic glycogen is the main buffer for blood glucose levels. Following a meal, hepatocytes take up glucose from the portal vein and store it as glycogen, a branched polymer of glucose residues. Hepatic glycogen content varies 2-fold during the day and can constitute up to 10% of the weight of the liver in humans. During periods of fasting and increased energy demands, hepatic glycogen can be broken down into glucose, which is released into the circulation to maintain blood glucose levels.
Due to its key role in human glucose homeostasis, hepatic glycogen level is an important indicator of the altered hepatic metabolism in a range of metabolic
Abbreviations: 2D, two-dimensional; CSI, chemical shift imaging; FA, flip angle; GC-MS, gas chromatography-mass spectrometry; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; RF, radiofrequency; SNR, signal to noise ratio; T, Tesla; TR, time of repetition; UTSW, University of Texas Southwestern.
disorders, including obesity, diabetes, and nonalcoholic fatty liver disease. For example, patients with type 2 diabetes have an impaired rate of glycogen synthesis following a meal, likely due to hepatic insulin resistance and/or an altered insulin to glucagon ratio. (1) Patients with poorly controlled type 1 diabetes can develop glycogenic hepatopathy, a rare disorder characterized by the accumulation of large amounts of hepatic glycogen that ultimately can lead to fibrosis and cirrhosis of the liver. (2) Genetic mutations in enzymes responsible for the synthesis or breakdown of glycogen cause glycogen storage diseases, a family of recessive disorders characterized by an abnormal quantity or quality of glycogen in the liver, muscles, heart, and kidney, depending on the specific molecular defect.
Glycogen metabolism in human patients initially was explored using [
H]-and [
14 C]-labeled tracers. (3, 4) Because of the constraints of radiotracers for clinical research, the gold standard for studying in vivo hepatic glycogen metabolism in humans is 13 C magnetic resonance spectroscopy (MRS) following oral intake of 13 C-labeled glucose. Hepatic glycogen metabolism has been extensively studied using this method in both physiologic and pathologic settings and following intake of various diets and/or drugs. Early studies conducted in the 1980s and 1990s determined the steady-state kinetics of liver glycogen synthesis in fasting and fed healthy individuals. (5, 6) Since then, hepatic glycogen metabolism has been studied by MRS in humans with a wide spectrum of traits or diseases, including obesity, (7) type 2 diabetes, (1) and glycogen storage disease. (8) Due to limited sensitivity, however, these previous MRS-based studies of glycogen metabolism relied on relatively low temporal resolutions, averaging signals of 13 minutes or longer (1, 5, (9) (10) (11) (12) ; that is, the earliest time point of hepatic glycogen assessment was 13 minutes after oral intake. (12) The hormonal and neuronal responses to oral food intake are nearly instant. For example, insulin is secreted from the pancreas and glucose is transported from the gut lumen across the enterocytes into the hepatic vein within minutes after glucose ingestion. (11, 13) Measuring immediate changes in hepatic glycogen synthesis would therefore require a better temporal resolution than 13 minutes. A fine-scale temporal resolution might provide new insights into the earliest postprandial phase of hepatic metabolism.
Studying the kinetics of hepatic glycogen synthesis during the earliest postprandial period (0-30 minutes) is technically challenging, in part due to the low signal to noise ratio (SNR), which typically requires longer acquisition times and averaging of the signal across many minutes. Alternative methods have been proposed to improve the sensitivity of detecting the glycogen signal. For instance, a novel method for detecting in vivo glycogen using water resonance in magnetic resonance imaging (MRI) was recently developed and validated in a mouse model. (14, 15) The method has been used in a proof of concept experiment in a recent human study at 3 Tesla (T), but further technological development is required for clinical usage. (16) Major advances have been made in radiofrequency (RF) technology during the past decades. The SNR has been improved by novel coil designs and by exploiting new MRI techniques, such as parallel imaging. (17) In particular, the recent translation of aRtiCle inFoRmation: dissolution dynamic nuclear polarization (or hyperpolarization) using 13 C-pyruvate accelerated the development of 13 C RF coils optimized for imaging various human organs. (18) (19) (20) In this study, we hypothesized that a state-of-the-art 13 C coil array design (volume carbon transmit coil, designed for hyperpolarized 13 C studies) may improve SNR of in vivo 13 C glycogen signals. We describe a highly sensitive 13 C MRS method that makes it possible to use commercially available technology to observe hepatic glycogen synthesis during the earliest postprandial phase in humans.
Participants and Methods

paRtiCipants
We recruited 3 healthy volunteers (38-51 years old, 2 men and 1 woman, all of white European descent). The study was approved by the ethical committee at the University of Texas Southwestern (UTSW) Medical Center. All volunteers provided written consent after having received oral and written information about the study. The participants arrived at the imaging facility at 7 am after an overnight fast. Before the MRS session, weight and height were measured, blood samples were drawn, and an intravenous access was established.
mRs
We used a system designed for imaging hyperpolarized 13 C MRS in human patients: a 3T wide-bore clinical MR scanner (750w Discovery; GE Healthcare), a clamshell 13 C transmit coil for RF excitation, and 8-channel 13 C receive array paddle-shaped coils for signal reception (dimension of each channel element, 5 × 10 cm; GE Healthcare). (19) Independent studies on a corn-oil phantom (square bottle, 3.78 L) and a 13 C]glucose in 240 mL). Nonsliceselective RF pulse (duration, 512 microseconds) was used for excitation, and the hepatic signal was localized by the paddle coil. 13 C MRS scans started concurrently with glucose ingestion and were repeated in 15-minute blocks for up to 3 hours. All free induction decay signals of individual scans were stored for reconstructing the spectra with various temporal resolutions. To confirm the spatial distribution of 
BioCHemiCal measuRements
Baseline blood samples were analyzed for plasma levels of lipids, lipoproteins, glucose, liver enzyme levels, and markers of kidney function, using standard clinical laboratory methods. Blood samples drawn every 15 minutes during the scan were analyzed for plasma levels of glucose and insulin (by enzyme-linked immunosorbent assay at the Metabolic Phenotyping Core of the UTSW Medical Center) and for 13 C-enrichment of glucose and lactate, using gas chromatography-mass spectrometry (GC-MS) at the Metabolomics Facility of the Children's Medical Center Research Institute at the UTSW Medical Center. The GC-MS analysis was performed on the upper phase of a Folch extraction, using 50 μL of plasma. Once dried, the sample was methoximated (10 mg/mL methoxyamine [226904; Sigma] in pyridine [270407; Sigma]) for 15 minutes at 70°C, then derivatized with N-(tert-butyldimethylsilyl)-Nmethyltrifluoroacetamide (394882; Sigma) for 1 hour at 70°C. We injected 1 μL of the sample on an Agilent 7890 gas chromatograph coupled to an Agilent 5975 mass selective detector. The detected abundances for the mass isotopomers corresponding to glucose (608-614) and lactate (261-264) were corrected for natural abundance.
Data analysis
All the 13 C data were processed using MATLAB (Mathworks; Natick, MA). For MRS, the raw data were apodized with a 5-Hz Gaussian filter, zero filled by a factor of 4, and a fast Fourier transform (FFT) applied. The data were analyzed in several temporal resolutions (30 seconds to 15 minutes) by averaging every 60 to 1,800 measurements. After averaging the spectra over time, the zeroth-and first-order phases were corrected in absorption mode. The resulting rolling baseline of the spectra was corrected by fitting to a spline function. Each metabolite was quantified by integrating the peak. For 13 C CSI, additional 2D apodization using a hanning filter, 2D zero filling by a factor of 4, and 2D inverse FFT was performed along the spatial domain. 
Results
Baseline CHaRaCteRistiCs
Baseline characteristics of the 3 volunteers are shown in Table 1 . We included 2 men and 1 woman, aged 38, 51, and 46 years, respectively. No volunteer had obesity or diabetes, and all had normal plasma levels of lipids and liver enzymes.
signal sensitiVity oF paDDle aRRay Coils
A sensitivity profile of the 8-channel 13 C paddle coils, using a bottle container of corn oil and a sphere phantom of 1-M [ (Fig. 2) . Overall, the dynamic patterns of labeled glucose and glycogen were similar in the 3 participants. When reconstructed with 1-minute temporal resolution, the [1- C]-glucose ingestion, and both signals declined toward baseline levels over the rest of the MRS session. With 15-minute temporal resolution, however, the glucose and glycogen peaks were at 15 and 30 minutes, respectively. Maximum signal intensity varied somewhat between the 3 participants, likely reflecting differences in body composition and/ or coil placements relative to the liver. The peak SNRs of glucose and glycogen were 76.4 ± 25.6 and 105.1 ± 49.7, respectively, with temporal resolution of 15 minutes, and 26.4 ± 25.6 and 30.3 ± 9.8, Abbreviations: ALT, alanine aminotransferase; F, female; HDL, high-density lipoprotein, LDL, low-density lipoprotein; M, male. 
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respectively, with temporal resolution of 1 minute. Depending on the subject, the data could be reconstructed with a finer temporal resolution (<1 minute). Clear 13 C-glucose and 13 C-glycogen signals from each spectrum when reconstructed every 30 seconds are shown, for example, in Fig. 2 (Supporting Fig. S1 ).
spatial loCaliZation oF [1-
C]-glyCogen peaKs to tHe liVeR
Although the spatial resolution was limited, separate 13 C CSI data confirmed the spatial localization of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-glycogen peaks in the liver (Fig. 3 ). In contrast, [1- 
plasma leVels oF gluCose, laCtate, anD insulin
Following oral ingestion of 98 g glucose (20% [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-labeled glucose), the fractional 13 C enrichment of glucose and lactate rose gradually in the plasma. At 2 hours after ingestion, approximately 20% of all plasma glucose and 5% of plasma lactate were 13 C labeled (data from participant 1 are shown in Fig. 4, top panels) . Plasma levels of glucose and insulin rose in the 3 participants, reaching peaks at approximately 60 and 90 minutes after intake, respectively, and decreased toward baseline after 60 to 90 minutes (Fig. 4, bottom panels) .
Discussion
In this study, we used 13 C MRS to observe rapid accumulation of hepatic [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-glycogen following orally administered [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]-glucose in 3 healthy adults aged 38 to 51 years. In all 3 participants, hepatic glycogen synthesis was detected by 13 C MRS as early as 2 minutes after ingestion of labeled glucose. Hepatic glycogen synthesis increased rapidly and peaked at approximately 20 minutes after ingestion. The method uses commercially available technology that may be applied for clinical use. The improved sensitivity of the presented technology to the 13 C-labeled glycogen signal allows in vivo assessment of dynamic glycogen synthesis every 30 seconds or longer, potentially allowing noninvasive assays and kinetic analysis of the enzymes associated with glycogen metabolism. Many drugs and hormones, such as glucagon and epinephrine, stimulate glycogenolysis with a timeframe of a few seconds. For instance, glucagon stimulates glycogenolysis and gluconeogenesis to raise plasma glucose, but the specific contribution of glycogenolysis versus gluconeogenesis is difficult to determine. Methods that measure glycogen on a minute to minute basis or even faster would allow exploration of such early response mechanisms. 
B A
Early studies have validated the use of nuclear magnetic resonance (NMR) techniques for measurement of 13 C metabolic fluxes in animal model systems. (21) The first study that reported natural abundance liver glycogen content in humans used a single 10-cm 13 C-only coil and a 2.1T NMR spectrometer. (22) The method was then further refined with the addition of a coplanar 1 H-decoupler. (12) The 1 H/ 13 C concentric surface coil 11/8 cm configuration reached a time resolution of ~13 minutes and has been used since then in several studies. (1, 5, 10, 23) In addition to measuring [1- load to be between 25% and 40%, depending on the amount of glucose and insulin reaching the liver. (24) Although our study was not designed to assess the metabolic flux of the labeled glucose in detail, it is interesting to note that 13 C-glucose and 13 C-glycogen accumulated rapidly in the liver at 2 minutes after ingestion, whereas 13 C-labeled glucose first appeared in plasma 30 minutes after ingestion. This suggests that the hepatic uptake of orally ingested glucose is close to 100% in the early postprandial phase and that glucose only passes directly into circulation once the hepatic capacity for metabolizing or storing glucose is surpassed. Thus, the presented method may be used to clarify the percentage of glucose passing directly to the circulatory system postprandially.
We also found that hepatic 13 C-glycogen decreased after approximately 30 minutes, whereas the fractional enrichment of 13 C-glucose in plasma increased from 30 minutes and throughout the remaining scan period. A possible explanation for this pattern is that the participants had been fasting for >12 hours at baseline and were likely relying on glycogenolysis and gluconeogenesis to maintain euglycemia. It is possible that the decreased 13 C-glycogen after 30 minutes reflects glycogenolysis of newly synthesized glycogen. We speculate that the last glucose residues incorporated (i.e., those derived from the labeled glucose load) are the first to be released during glycogenolysis. Studies in myofibroblasts support such a "last-in firstout" model of glycogenolysis. (25) It is possible that the pattern would be different in recently fed individuals. We hypothesize that the decrease in 13 C-glycogen after 30 minutes would be blunted (or absent) in recently fed individuals after ingestion of labeled glucose compared to the fasting subjects included in our study.
It should be noted that the 13 C spectra shown here can be further refined by proton decoupling, which was not available in the MR scanner that we used. For example, the SNR of [1-
13 C]-glycogen peak can be significantly improved by decoupling the 1 H nuclei. (12, 26) Moreover, a recent study showed that hepatic mitochondrial oxidative and anaplerotic fluxes can be measured from infused [1- 13 C]-acetate by measuring [5- 13 C]-and [1-13 C]-glutamate, using 1 H-decoupled 13 C MRS. (27) Exploiting 1 H decoupling, however, requires caution as it increases substantial RF power deposition, which might easily exceed the specific absorption rate limit.
Our study has limitations that should be further investigated. First, we only studied 3 healthy middleaged adults of white descent and without obesity. The results may therefore not necessarily be generalizable to subjects with different characteristics. For instance, coil placement relative to the liver appeared to majorly influence the sensitivity of the method. It is likely that sensitivity to detect glycogen will be lower in individuals with obesity in whom abdominal fat may hinder placement of the coil in proximity to the liver. Moreover, as the clamshell-paddle coil configuration samples 13 C signals from a larger region than coplanar surface coils, the measured spectra likely contain signals from tissue regions other than the liver. In particular, muscle can convert glucose to glycogen under the experimental conditions. However, as the contribution of intracellular and vascular glucose in the liver is minimal, the 13 C peaks detected in the liver by the CSI image is primarily glycogen in the liver (Fig. 3 , white arrows). Another limitation is that we did not measure absolute levels of hepatic glycogen in our participants. This would have required the inclusion of phantoms with known glycogen concentrations during the scan. We suggest that future studies using the method should include glycogen phantoms, given that the absolute glycogen content of the liver is a biologically as well as clinically relevant measurement.
In conclusion, we observed rapid accumulation of hepatic [1- 13 C]-glycogen following orally administered [1- 13 C]-glucose, using a sensitive, highresolution, time-resolved 13 C MRS method. This method, which is based on commercially available and clinically used technology, may be useful for future studies of hepatic glycogen metabolism in humans.
